Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Melinda G. Hollingshead
Molecular Pharmacodynamics-Guided Scheduling of Biologically Effective Doses: A Drug Development Paradigm Applied to MET Tyrosine Kinase Inhibitors
Molecular Cancer Therapeutics
Cancer Research
Oncology
Artemisinin Dimer Anticancer Activity Correlates With Heme-Catalyzed Reactive Oxygen Species Generation and Endoplasmic Reticulum Stress Induction
International Journal of Cancer
Cancer Research
Oncology
Related publications
Molecular Imaging of C-Met Tyrosine Kinase Activity
Analytical Biochemistry
Biochemistry
Cell Biology
Molecular Biology
Biophysics
From Oncogene to Drug: Development of Small Molecule Tyrosine Kinase Inhibitors as Anti-Tumor and Anti-Angiogenic Agents
Oncogene
Cancer Research
Genetics
Molecular Biology
Discovery of New Thiophene, Pyrazole, Isoxazole Derivatives as Antitumor, C-Met, Tyrosine Kinase and Pim-1 Kinase Inhibitors
Bulletin of the Chemical Society of Ethiopia
Chemistry
Novel Bruton's Tyrosine Kinase Inhibitors Currently in Development
OncoTargets and Therapy
Oncology
Pharmacology
Personalized Therapy of Tyrosine Kinase Inhibitors
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Tyrosine Kinase Inhibitors for Diabetes
Science-Business eXchange
A Case of EGFR Mutant Lung Adenocarcinoma That Acquired Resistance to EGFR-tyrosine Kinase Inhibitors With MET Amplification and Epithelial-To-Mesenchymal Transition
OncoTargets and Therapy
Oncology
Pharmacology
Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance
Cancers
Cancer Research
Oncology
Tyrosine Kinase Inhibitors in Lung Cancer
Hematology/Oncology Clinics of North America
Oncology
Hematology
